Pharmaceuticals

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

  • APA248279
  • April 2018
  • Pharmaceuticals

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in loss of vision and permanent eye damage that arises with the development of infections such as glaucoma, retinal edema or cataract. Anterior uveitis can be treated with eye drops containing anti-inflammatory drugs. It usually responds well to treatment. However, there may be a tendency of the condition to re-occur. Uveitis remains a less-explored research indication that involves diverse therapeutics as treatment options including corticosteroids and biologics. Corticosteroids showed significant results to cure the condition and researchers are currently exploring biological therapies to treat anterior uveitis. Introduction of biologics such as Humira (Adalimumab) for the treatment uveitis is driving the growth of anterior uveitis market in Asia pacific. Exploring new drugs and expanding therapeutic applications of existing drugs to include and effectively treat uveitis offers significant growth opportunity for companies involved in uveitis market. 



The Asia pacific anterior uveitis market is segmented on the basis of therapeutics and geography. Diverse range of therapeutics are used to treat anterior uveitis, which includes corticosteroids (prednisolone), anti-inflammatory drugs, antimetabolites (methotrexate), antidiabetics (metformin), biologics and other drugs. Anti-inflammatory drugs and glucocorticoids are primarily recommended treatment options to cure anterior uveitis. Focus of research companies on biological drugs is expected to fuel the market growth in near future. Geographically, the Asia Pacific anterior uveitis market is segmented into China, Japan, India, Australia and others. High unmet healthcare needs and rising generic market potentiates the growth of anterior uveitis treatment in Asia pacific. Moreover, high prevalence of eye infections in Asia pacific region presents promising opportunity for drug manufacturers to invest in Asia pacific region. 



Amdipharm Mercury Company Limited, Novartis AG and Santen pharmaceuticals are some of the key companies in Asia pacific anterior uveitis market. Key players of this market are focusing on clinical trials to commercialize their pipeline therapeutics to gain the competitive advantage.



KEY TAKE AWAYS



•    Widespread coverage of the Asia pacific anterior uveitis market including drivers, restrains and opportunities are listed in this report that would assist professionals to understand the market behavior 

•    Projections in this report are made by analyzing  current market trends and the market potential for the analysis period 2014‐2020, in terms of value

•    A comprehensive analysis of different segments helps to recognize and explore promising prospects within the Asia pacific anterior uveitis market 

•    Porter’s five forces framework provided in the report examines the competitive structure of Asia pacific anterior uveitis market and helps in a strategic industry analysis

•    A comprehensive assessment of key leaders, technological advances and a pipeline research conducted across the Asia pacific anterior uveitis market, would prove informative to professionals in corporate sector 

•    Ease of doing business analysis should help in making strategic business decisions



KEY MARKET SEGMENTS 



The Asia pacific anterior uveitis market is segmented into two categories viz., therapeutics and geography. 



MARKET BY THERAPEUTICS

•    Corticosteroids (prednisolone)

•    Anti-inflammatory agents

•    Cycloplegics (atropine or homatropine)

•    Antimetabolites (methotrexate)

•    Anti-virals (aciclovir or valaciclovir)

•    Anti-diabetic (metformin)

•    Biologics (mAbs)

•    Others



MARKET BY GEOGRAPHY

•    China

•    Japan

•    India

•    Australia

•    Others


Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

April 2018| $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

April 2018| $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

April 2018| $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

April 2018| $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

April 2018| $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

April 2018| $2850 | Pre Book Price:$2494

2019 © Copyright Big Market Research

View Pricing >>